541 related articles for article (PubMed ID: 32573724)
1. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
[TBL] [Abstract][Full Text] [Related]
2. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
[TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma to treat COVID-19.
Bloch EM
Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
[No Abstract] [Full Text] [Related]
4. Use of convalescent plasma in COVID-19 patients in China.
Zhu M; Hu K; Zhu Z
Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
[No Abstract] [Full Text] [Related]
5. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
6. Why should we use convalescent plasma for COVID-19?
Franchini M
Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
[No Abstract] [Full Text] [Related]
7. The resurgence of convalescent plasma therapy.
The Lancet Haematology
Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
[No Abstract] [Full Text] [Related]
8. Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report.
Xu TM; Lin B; Chen C; Liu LG; Xue Y
Virol J; 2020 Jun; 17(1):80. PubMed ID: 32560646
[TBL] [Abstract][Full Text] [Related]
9. Convalescent Plasma: Promise for COVID-19 Pandemic.
Sheikh S; Baig MA
J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
[No Abstract] [Full Text] [Related]
10. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
Nnaji CA; Iwu CJ; Ndwandwe DE; Jordan P; Wiysonge CS
S Afr Med J; 2020 Jul; 110(8):759-760. PubMed ID: 32880303
[TBL] [Abstract][Full Text] [Related]
11. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
[TBL] [Abstract][Full Text] [Related]
12. Treatment of COVID-19: old tricks for new challenges.
Cunningham AC; Goh HP; Koh D
Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
[No Abstract] [Full Text] [Related]
13. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: Main therapeutic options.
Hachfi W; Ben Lasfar N
Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
[No Abstract] [Full Text] [Related]
15. A Novel Approach Using Social Media to Solve Medical Ethical Dilemmas and Legal Risks in the Emergencies of COVID-19.
Wan J; Huang Y; Aljaafreh AAHA; Dong D; Cong Y; Lin J; Chen H
Am J Bioeth; 2020 Jul; 20(7):W12-W14. PubMed ID: 32716772
[No Abstract] [Full Text] [Related]
16. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
[TBL] [Abstract][Full Text] [Related]
17. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
Garraud O
Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
[No Abstract] [Full Text] [Related]
18. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
Majbour N; El-Agnaf O
Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
[TBL] [Abstract][Full Text] [Related]
19. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
Farrugia A
Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
[No Abstract] [Full Text] [Related]
20. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
